Why is Morepen Labs. falling/rising?

As of 26-Aug, Morepen Laboratories Ltd is experiencing a decline in its stock price, currently at 47.31, which reflects a decrease of 0.93 or 1.93%. The stock has been on a downward trend, losing value for the last four consecutive days and showing a total decline of 4.89% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. The stock's performance over the past week and month has also been poor, with returns of -3.15% and -21.07%, respectively. The company has reported negative results for the last two consecutive quarters, with a significant drop in net sales and profits, contributing to a lack of investor confidence, as evidenced by a 45.11% decrease in delivery volume compared to the 5-day average.
In the broader market context, Morepen Laboratories Ltd's recent performance contrasts sharply with the Sensex, which has only declined by 1.05% over the past week. This underperformance is further highlighted by the stock's year-to-date return of -39.58%, while the Sensex has gained 3.39% during the same period. The company's low debt-to-equity ratio and attractive valuation metrics are overshadowed by its poor long-term growth prospects and declining sales figures. The lack of interest from domestic mutual funds, which hold 0% of the company, suggests that institutional investors are not confident in the stock's future, reinforcing the negative sentiment surrounding Morepen Laboratories Ltd.